🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Islam Hassan

ORCID: 0000-0002-9581-5290

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial”.

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0611

N/A

4.8DataRank · unranked

264 citations

Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú +16 more

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Neuro-Oncology(2022)10.1093/neuonc/noac086

N/A

0DataRank · unranked

23 citations

Elizabeth R. Gerstner, Andrew B. Lassman, Caroline Chung, Howard Colman, Patricia E. Cole +21 more

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac124

N/A

0DataRank · unranked

10 citations

Akifumi Hagiwara, Blaine S.C. Eldred, Catalina Raymond, Chencai Wang, Francesco Sanvito +8 more